Institut de Neurociències (INc) - UAB Barcelona

The Innovation Network of New Technologies in Mental Health (TECSAM) has been created

The Innovation Network of New Technologies in Mental Health (TECSAM) has been created

The laboratory coordinated by Drs. Antonio Armario and Roser Nadal, together with other 28 research teams, created the Innovation Network of New Technologies in Mental Health (TECSAM). TECSAM aims to integrate all mental health research carried out in the territory, optimising the resources allocated to the valorisation and transfer of knowledge. Dr. Josep Maria Haro, from Parc Sanitari Sant Joan de Déu, will be the coordinator of the network.

09/12/2020

The goal of the Innovation Network of New Technologies in Mental Health (TECSAM) is to provide treatment to all people with mental health disorders and to improve the quality of life of persons with severe mental health disorders and their families through 1) technological advances based on research results and 2) the detection of needs that would signal areas with treatment gaps.

The network has a total of 29 groups, belonging to different institutions in the field of research into mental health diseases and technologies in Catalonia. There is representation mainly from research centres, hospitals and universities. Out of a total of 284 researchers, 162 are women.



Related news

The H2020 project QSPainRelief awarded by the European Commission

The H2020 project QSPainRelief awarded by the European Commission

The QSPainRelief project "Effective combinational treatment of chronic pain in individual patients by an innovative quantitative systems pharmacology pain relief approach", which includes the participation of Dr. Jesús Giraldo’s team (Institute for Neurosciences and Biostatistics Unit of the School of Medicine), has been funded from the European Commission.

This  project will attempt to solve a crucial problem since about 20% of Europeans suffer from chronic pain and current therapies are not effective in many cases. Around 60% of patients do not reach enough relief from traditional painkillers, which in turn can lead to several adverse effects.

The QSPainRelief project addresses the problem of chronic pain by identifying new drug combinations that are expected to increase analgesic efficacy while reducing side effects. To do this, quantitative systems pharmacology and computational modeling will be used. The best combinations will be validated in animal models and clinical studies.

The QSPainRelief project will receive more than € 6 million in funding for 5 years through the H2020 program. The project is a collaboration between 9 research institutions from 6 different countries, including the UAB, starting January 1, 2020.

A new model of the worm C. elegans to progress in the study of a rare disease of the nervous system

A new model of the worm C. elegans to progress in the study of a rare disease of the nervous system

In a research co-directed by Dr Esther Dalfó, researcher at the Institute and professor at UVic-UCC, a model of chromosome X-linked adrenoleukodystrophy (x-ALD) has been indentified in the earthworm C. elegans.

The model will permit to accelerate and reduce the price of the research, which is studying the mechanisms and the possible pharmacological targets for the neuronal alterations of this disease.

The earliest results of studies with this organism point to glial cells as a man responsible for the neurological damage caused by the disease.

The work was done at the IDIBELL Neurometabolic Diseases group, with international collaborations, and has been published in the Free Radical Biology and Medicine journal.

Read the article

View all news